Kewaunee Scientific Corporation
KEQU
$41.53
-$1.61-3.73%
NASDAQ
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 263.18M | 240.47M | 220.03M | 199.64M | 202.31M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 263.18M | 240.47M | 220.03M | 199.64M | 202.31M |
| Cost of Revenue | 185.88M | 171.62M | 160.57M | 146.53M | 149.68M |
| Gross Profit | 77.30M | 68.86M | 59.46M | 53.11M | 52.63M |
| SG&A Expenses | 57.31M | 51.10M | 44.68M | 36.81M | 35.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 243.19M | 222.71M | 205.25M | 183.34M | 185.38M |
| Operating Income | 19.99M | 17.76M | 14.78M | 16.30M | 16.93M |
| Income Before Tax | 16.28M | 14.79M | 8.98M | 11.22M | 12.14M |
| Income Tax Expenses | 3.77M | 3.20M | -8.83M | -7.74M | -6.64M |
| Earnings from Continuing Operations | 12.50 | 11.58 | 17.82 | 18.97 | 18.78 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -199.00K | -178.00K | -234.00K | -217.00K | -308.00K |
| Net Income | 12.31M | 11.41M | 17.58M | 18.75M | 18.47M |
| EBIT | 19.99M | 17.76M | 14.78M | 16.30M | 16.93M |
| EBITDA | 25.21M | 22.24M | 18.79M | 19.55M | 20.15M |
| EPS Basic | 4.30 | 3.99 | 6.15 | 6.55 | 6.44 |
| Normalized Basic EPS | 3.49 | 3.17 | 2.76 | 3.25 | 3.40 |
| EPS Diluted | 4.13 | 3.83 | 5.91 | 6.31 | 6.23 |
| Normalized Diluted EPS | 3.35 | 3.04 | 2.65 | 3.13 | 3.31 |
| Average Basic Shares Outstanding | 11.45M | 11.45M | 11.45M | 11.47M | 11.50M |
| Average Diluted Shares Outstanding | 11.91M | 11.92M | 11.91M | 11.88M | 11.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |